Mandukaparni (Centella asiatica) ↔ Modern Wound-Healing & Venous Insufficiency Pharmacotherapy

Mandukaparni is one of Charaka's four Medhya Rasayanas and the rare classical drug that became a registered pharmaceutical in Europe — its asiaticoside-driven wound-healing and TECA-based venous-insufficiency evidence is genuinely strong, though it is frequently and incorrectly confused with Brahmi (Bacopa monnieri).

IN PLAIN LANGUAGE

Mandukaparni, one of Ayurveda's four great memory-supporting herbs, is also the rare traditional remedy that became a registered medicine in Europe for wound healing and vein problems in the legs — genuinely strong evidence, though it's often mixed up with a different herb, Brahmi.

Ayurveda offers a long tradition using this plant for both memory and healing; modern medicine offers a standardised, clinically-tested pharmaceutical form of the same plant with real registered-drug status for venous and wound conditions.

WHEN TO SEEK CARE

See a doctor for a wound that isn't healing or looks infected, or for new leg swelling and pain, which needs to be checked for a blood clot before assuming it's simple venous insufficiency.

🔴 REFER IMMEDIATELY

A chronic wound not improving with standard care, or one showing signs of infection (spreading redness, pus, fever)
Leg swelling, pain, or skin changes suggestive of venous insufficiency or deep vein thrombosis needing proper diagnosis before self-treatment
Confusing Mandukaparni (Centella asiatica) with Brahmi (Bacopa monnieri) when purchasing a specific standardised product
Signs of wound infection
Suspected deep vein thrombosis (unilateral leg swelling, pain, warmth)
Non-healing or worsening chronic wound

🟢 SUITABLE FOR ROUTINE / COLLABORATIVE CARE

AYURVEDA SCOPE

Traditional Mandukaparni swarasa/churna for general medhya rasayana purposes, and topical use for minor wound care.

MODERN MEDICINE SCOPE

Diagnosis of chronic venous insufficiency (including exclusion of DVT) and prescription of standardised TECA where clinically indicated.

COLLABORATIVE SCOPE

A patient interested in Mandukaparni for venous or wound complaints benefits from knowing that a standardised, registered-pharmaceutical form (TECA) of the same plant has the strongest trial evidence, and should have DVT excluded before self-treating leg swelling.

Sign in to read the full comparison

The plain-language summary and safety guidance above are free for everyone. The 10-dimension scholarly comparison needs an account.